Published online Nov 15, 2025. doi: 10.4251/wjgo.v17.i11.112089
Revised: August 25, 2025
Accepted: October 22, 2025
Published online: November 15, 2025
Processing time: 107 Days and 17.3 Hours
Primary gastrointestinal lymphoma (PGIL) is a relatively uncommon clinical entity, exhibiting distinctive features including occult primary sites, nonspecific clinical presentations, and considerable diagnostic and therapeutic difficulties. Consequently, comprehensive clinical investigations into its clinicopathological characteristics and surgical intervention value are warranted to enhance dia
To investigate the clinicopathological characteristics and surgical significance of PGIL from a surgical perspective, providing a theoretical basis for optimizing diagnostic and therapeutic strategies.
This study included 50 cases of PGIL treated by the General Surgery Department of the Chinese PLA Air Force Medical Center from June 2001 to March 2025. Data were extracted from the Electronic Medical Record system for retrospective analysis. A retrospective analysis was conducted on their epidemiological, clinical manifestations, imaging, pathological features, and treatment outcomes. Descriptive statistics were applied for data summarization, with continuous variables presented as frequencies and percentages. Correlations between variables were assessed using the Spearman rank correlation coefficient.
All cases had the gastrointestinal tract as the primary site. Abdominal pain was the most common initial symptom (52.0%), with 80.0% of patients experiencing pain during the course of the disease, and 38.0% experiencing hema
Diffuse large B-cell lymphoma is the primary PGIL subtype. Imaging and endoscopic biopsy are diagnostic es
Core Tip: Primary gastrointestinal lymphoma predominantly manifests as diffuse large B-cell lymphoma, with abdominal pain as the leading symptom. Comprehensive diagnosis relies on imaging (computed tomography sensitivity: 94.3%) and endoscopic biopsy (detection rate: 91.5%). Surgery is pivotal for definitive diagnosis (via complete specimen acquisition), emergency management (e.g., obstruction/perforation), and primary lesion resection, particularly for tumors > 5 cm (26.5% complication rate). While combined surgery and chemotherapy showed higher improvement rates than chemotherapy alone, statistical significance was not reached. Integration of surgical strategies into multimodal therapy may optimize outcomes, emphasizing individualized approaches based on tumor size, stage, and complications.
